Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
LISA Laser is a surgical laser and medical device business focused on minimally invasive digital and laser-assisted surgery, particularly in urology and soft-tissue procedures. The business develops and commercializes Thulium, Holmium, and CO2 laser systems, with products used for benign prostatic hyperplasia, stone management, and other surgical applications. In August 2018, OmniGuide Holdings acquired LISA Laser Products OHG, and the business now operates under the legal entity LISA Laser Products GmbH as a wholly owned subsidiary. Development, manufacturing, sales, marketing, and support continue from Katlenburg-Lindau, Germany. The company appears to be a commercial-stage medtech business rather than a therapeutics developer, so it does not have a traditional biotech drug pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on LISA Institute for Digital Surgery.